The FDA has cleared the CATS®-D Disposable Tonometer Prism for sale in the United States, assuring that eye care clinicians have accurate intraocular pressure (IOP) measurement data — a key metric — for the diagnosis and treatment of glaucoma and other serious ocular conditions.
The patented CATS®-D Tonometer Prism is designed to deliver improved IOP measurement accuracy with a sterile, disposable tip replacement for the Goldmann tonometer.
Reaction time helps measure healthy vs. diseased brains, revealing potential connections tied to the risk of Alzheimer’s disease and dementiaContinue reading
TUCSON, Ariz., July 8, 2021 — Critical Path Institute (C-Path) today announced the appointment of health care industry leader and active civic involvement pioneer Mara G. Aspinall, MBA, to its Board of Directors.Continue reading
Scottie Kern and Dr. Terina N. Martínez Will Both Serve in Dual Positions
TUCSON, Ariz., June 24, 2021 — Critical Path Institute (C-Path) today announced it has named Scottie Kern, as both Executive Director of the Electronic Patient-Reported Outcome (ePRO) Consortium and Associate Director of the Patient-Reported Outcome (PRO) Consortium and Terina N. Martínez, Ph.D., as Executive Director of both the Duchenne Regulatory Science Consortium (D-RSC) and Critical Path to Therapeutics for the Ataxias (CPTA).Continue reading
TUCSON, Ariz., June 22, 2021 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has received the first commercial orders for its planned HTG Transcriptome Panel and has signed agreements with its first two Early Adopter Program (EAP) collaborators in Europe. HTG has now signed EAP agreements with customers in both the US and Europe and continues to progress toward its planned third quarter 2021 commercial launch of its HTG Transcriptome Panel, designed to measure approximately 20,000 mRNA targets using the HTG EdgeSeq technology.Continue reading
As the 17th president of NAU, José Luis Cruz Rivera has spent time talking with faculty, staff, students and community members, working with university leaders to plan for the fall semester and officially introducing himself and discussing his vision for the university.Continue reading
For the third consecutive year, ASU is in the top 10 for U.S. patents issued to U.S. universities — and 11th worldwide — according to an annual ranking of the top universities by the National Academy of Inventors and the Intellectual Property Owners Association.Continue reading
The CSBI-TEConomy Life Science Workforce Trends Report reflects Continued Resilience Amidst a Global Pandemic, Adjusting to Remote Work, and Advancing a More Diverse and Inclusive Industry. The report debuted at BIO Digital on June 17, 2021.
The additional FDA clearance provides broad flexibility to choose either 1MHz or 2MHz for treatment
PHOENIX, June 8, 2021 /PRNewswire/ — bioSyntagma®, Inc unveiled the world’s first high-plex multi-omic spatial workflow designed for clinical samples and diagnostic applications. Compatible with FFPE and large resections up to an inch in size, the Molecular Fingerprint™ (mPrint) technology has been demonstrated to map tumor microenvironments with custom PCR panels, targeted and total sequencing, and spatial imaging at resolutions ranging from single-cell to complex regions of interest. bioSyntagma’s solution is the first to provide a pathway to diagnostic applications with its proprietary spatial-diagnostic machine learning engine that classifies tissues based on tumor microenvironment. Continue reading